HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

zosuquidar trihydrochloride (LY335979)

multidrug resistance modulator; structure in first source
Also Known As:
LY335979; (2R)-anti-5-(3-(4-(10,11-difluoromethanodibenzo-suber-5-yl)piperazin-1-yl)2-hydroxypropoxy)quinoline trihydrochloride; LY 335979; RS 33295-198; RS-33295-198
Networked: 12 relevant articles (1 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Burgess, Michael: 2 articles (04/2007 - 07/2004)
2. Briglia, Marilena: 1 article (01/2015)
3. Faggio, Caterina: 1 article (01/2015)
4. Lang, Florian: 1 article (01/2015)
5. Fazio, Antonella: 1 article (01/2015)
6. Sane, Rucha: 1 article (05/2012)
7. Podila, Lalitha: 1 article (05/2012)
8. Mease, Kirsten: 1 article (05/2012)
9. Taub, Mitchell E: 1 article (05/2012)
10. Harpstrite, Scott E: 1 article (07/2010)

Related Diseases

1. Leukemia
2. Sarcoma (Soft Tissue Sarcoma)
3. Breast Neoplasms (Breast Cancer)
4. Non-Hodgkin Lymphoma (Lymphosarcoma)
5. Neoplasms (Cancer)

Related Drugs and Biologics

1. Doxorubicin (Adriamycin)
2. Vincristine (Oncovin)
3. P-Glycoprotein
4. zosuquidar trihydrochloride (LY335979)
5. Multidrug Resistance-Associated Proteins
6. ATP-Binding Cassette Transporters (ABC Transporters)
7. docetaxel (Taxotere)
8. VAP-cyclo protocol
9. Paclitaxel (Taxol)
10. Etoposide (VP 16)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Drug Therapy (Chemotherapy)